Protagonist Therapeutics (NasdaqGM:PTGX) Earnings Call Presentation
Protagonist Therapeutics(US:PTGX)2026-03-18 12:30US FDA Approval of ICOTYDETM (Icotrokinra) For Treatment of Moderate -to - Severe Plaque Psoriasis Dinesh V. Patel, Ph.D. President & CEO Conference Call March 18, 2026 1 Legal Disclaimer This presentation and any accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. All statements other than statements of historical facts contained in this presentation are forward-looking statements, including statements regarding: the timing a ...